Published in Liver Transpl on October 01, 2005
Emergency abdominal surgery after solid organ transplantation: a systematic review. World J Emerg Surg (2016) 0.76
ACUTE APENDICITIS IN LIVER TRANSPLANT RECIPIENTS. Arq Bras Cir Dig (2016) 0.75
Urinary-cell mRNA profile and acute cellular rejection in kidney allografts. N Engl J Med (2013) 7.40
Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. Liver Transpl (2012) 4.65
Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science (2012) 4.20
Homeostatic proliferation is a barrier to transplantation tolerance. Nat Med (2003) 4.12
Therapeutic siRNA silencing in inflammatory monocytes in mice. Nat Biotechnol (2011) 3.95
Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization. Gastroenterology (2008) 2.95
Informing candidates for solid-organ transplantation about donor risk factors. N Engl J Med (2008) 2.83
Improvement in survival associated with adult-to-adult living donor liver transplantation. Gastroenterology (2007) 2.72
Liver transplantation from controlled non-heart-beating donors: an increased incidence of biliary complications. Transplantation (2003) 2.63
Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade. PLoS Pathog (2009) 2.57
Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects. Diabetes (2004) 2.22
Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function. Transplantation (2004) 2.13
Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era. Hepatology (2011) 2.01
Survival following liver transplantation from non-heart-beating donors. Ann Surg (2004) 1.96
Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome. Liver Transpl (2004) 1.95
Donor morbidity after living donation for liver transplantation. Gastroenterology (2008) 1.90
Renal function after orthotopic liver transplantation is predicted by duration of pretransplantation creatinine elevation. Liver Transpl (2005) 1.87
Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice. FASEB J (2008) 1.76
Lack of benefit of pre-transplant locoregional hepatic therapy for hepatocellular cancer in the current MELD era. Liver Transpl (2006) 1.72
Geographic inequity in access to livers for transplantation. Transplantation (2011) 1.71
Sewing needles embedded in the cardiac interventricular septum and chest wall. J Thorac Cardiovasc Surg (2010) 1.68
Endoscopic management of biliary complications after adult living donor liver transplantation. Am J Gastroenterol (2004) 1.68
Insulin independence following isolated islet transplantation and single islet infusions. Ann Surg (2003) 1.67
Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma. Mol Med (2008) 1.61
Laboratory test results after living liver donation in the adult-to-adult living donor liver transplantation cohort study. Liver Transpl (2011) 1.59
Transplantation: impact of pretransplant renal insufficiency. Liver Transpl (2008) 1.58
Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transpl (2010) 1.56
Accelerated memory cell homeostasis during T cell depletion and approaches to overcome it. J Immunol (2006) 1.51
Use of EBV PCR for the diagnosis and monitoring of post-transplant lymphoproliferative disorder in adult solid organ transplant patients. Am J Transplant (2002) 1.49
GITR Blockade Facilitates Treg Mediated Allograft Survival. Transplantation (2009) 1.48
Cutting edge: transplant tolerance induced by anti-CD45RB requires B lymphocytes. J Immunol (2007) 1.47
Immune rejection after pancreatic islet cell transplantation: in vivo dual contrast-enhanced MR imaging in a mouse model. Radiology (2012) 1.41
Ascites after liver transplantation--a mystery. Liver Transpl (2004) 1.40
Promotion of allograft survival by CD4+CD25+ regulatory T cells: evidence for in vivo inhibition of effector cell proliferation. J Immunol (2004) 1.34
Elevated portal vein drug levels of sirolimus and tacrolimus in islet transplant recipients: local immunosuppression or islet toxicity? Transplantation (2003) 1.32
{beta}-Cell function following human islet transplantation for type 1 diabetes. Diabetes (2005) 1.28
Biliary casts after orthotopic liver transplantation: clinical factors, treatment, biochemical analysis. Am J Gastroenterol (2003) 1.23
Interleukin-6 from intrahepatic cells of bone marrow origin is required for normal murine liver regeneration. Hepatology (2002) 1.23
Living donor liver transplantation: summary of a conference at The National Institutes of Health. Liver Transpl (2002) 1.22
Pretransplant model to predict posttransplant survival in liver transplant patients. Ann Surg (2002) 1.22
Delayed hepatocellular carcinoma model for end-stage liver disease exception score improves disparity in access to liver transplant in the United States. Hepatology (2015) 1.20
Allograft survival following adult-to-adult living donor liver transplantation. Am J Transplant (2004) 1.20
Summary report of a national conference: Evolving concepts in liver allocation in the MELD and PELD era. December 8, 2003, Washington, DC, USA. Liver Transpl (2004) 1.19
Expansion and conversion of human pancreatic ductal cells into insulin-secreting endocrine cells. Elife (2013) 1.19
Islet cell hormonal responses to hypoglycemia after human islet transplantation for type 1 diabetes. Diabetes (2005) 1.16
TGF-β-producing regulatory B cells induce regulatory T cells and promote transplantation tolerance. Eur J Immunol (2014) 1.15
Transplantation for type I diabetes: comparison of vascularized whole-organ pancreas with isolated pancreatic islets. Ann Surg (2004) 1.15
Hospitalization rates before and after adult-to-adult living donor or deceased donor liver transplantation. Ann Surg (2010) 1.13
Superior survival using living donors and donor-recipient matching using a novel living donor risk index. Hepatology (2014) 1.12
A multicenter evaluation of safety of early extubation in liver transplant recipients. Liver Transpl (2007) 1.10
Complications related to dapsone use for Pneumocystis jirovecii pneumonia prophylaxis in solid organ transplant recipients. Am J Transplant (2005) 1.09
Liver and intestine transplantation: summary analysis, 1994-2003. Am J Transplant (2005) 1.09
Glycemic thresholds for activation of counterregulatory hormone and symptom responses in islet transplant recipients. J Clin Endocrinol Metab (2006) 1.04
The use of non-heart-beating donors for isolated pancreatic islet transplantation. Transplantation (2003) 1.03
Antibody-induced transplantation tolerance that is dependent on thymus-derived regulatory T cells. J Immunol (2006) 1.03
Factors differentially correlated with the outcome of liver transplantation in hcv+ and HCV- recipients. Transplantation (2004) 1.02
Risk for immune-mediated graft dysfunction in liver transplant recipients with recurrent HCV infection treated with pegylated interferon. Gastroenterology (2012) 1.01
Comparison of open, laparoscopic, and hand-assisted approaches to live-donor nephrectomy. Transplantation (2002) 0.99
Early adaptation of human lower extremity vein grafts: wall stiffness changes accompany geometric remodeling. J Vasc Surg (2004) 0.99
Resistance to anti-CD45RB-induced tolerance in NOD mice: mechanisms involved. Transpl Int (2004) 0.99
The outcome of liver grafts procured from hepatitis C-positive donors. Transplantation (2002) 0.98
HLA sensitization in islet transplantation. Clin Transpl (2006) 0.97
Evidence for allograft rejection in an islet transplant recipient and effect on beta-cell secretory capacity. J Clin Endocrinol Metab (2007) 0.96
The faltering solid organ donor pool in the United States (2001-2010). World J Surg (2012) 0.95
Determinants of transplant surgeons' willingness to provide organs to patients infected with HBV, HCV or HIV. Am J Transplant (2005) 0.95
Liver transplantation in children: update 2010. Pediatr Clin North Am (2010) 0.95
Toward further expansion of the organ pool for adult liver recipients: splitting the cadaveric liver into right and left lobes. Transplantation (2002) 0.94
Phase 2 trial of bevacizumab, capecitabine, and oxaliplatin in treatment of advanced hepatocellular carcinoma. Cancer (2011) 0.94
Liver transplantation for metastatic neuroendocrine tumor: a case report and review of the literature. World J Gastroenterol (2005) 0.93
Early kidney dysfunction post liver transplantation predicts late chronic kidney disease. Transplantation (2004) 0.93
Serum cytokine profiles associated with early allograft dysfunction in patients undergoing liver transplantation. Liver Transpl (2012) 0.93
Pattern of ischemia reperfusion injury in a mouse orthotopic liver transplant model. J Surg Res (2004) 0.92
Tai chi as a balance improvement exercise for older adults: a systematic review. J Geriatr Phys Ther (2010) 0.92
Diaphragmatic hernia occurring 15 months after percutaneous radiofrequency ablation of a hepatocellular cancer. Am Surg (2008) 0.92
Salvage of nonmaturing native fistulas by using angioplasty. Radiology (2006) 0.92
IL-21 is an antitolerogenic cytokine of the late-phase alloimmune response. Diabetes (2011) 0.92
CD25+ immunoregulatory CD4 T cells mediate acquired central transplantation tolerance. J Immunol (2003) 0.91
Expanded-criteria donor kidneys: a single-center clinical and short-term financial analysis--cause for concern in retransplantation. Transplantation (2004) 0.91
Late surgical complications following liver transplantation. Liver Transpl (2009) 0.90
Effect of glucagon-like peptide-1 on beta- and alpha-cell function in isolated islet and whole pancreas transplant recipients. J Clin Endocrinol Metab (2008) 0.90
Dexamethasone inhibits early regenerative response of rat liver after cold preservation and transplantation. Hepatology (2003) 0.89
Sequential liver and bone marrow transplantation for treatment of erythropoietic protoporphyria. Pediatrics (2006) 0.89